Under the patronage of Sheikha bint Saif, Burjeel Holdings launches Thalassemia and Sickle Cell Centre
14 May 2025 10:11
ABU DHABI (ALETIHAD)Under the patronage of Sheikha Shaikha bint Saif bin Mohamed Al Nahyan, wife of His Highness Sheikh Sultan bin Khalifa Al Nahyan, Advisor to His Highness the President, and Chairperson of the Emirates Thalassemia Society, Burjeel Holdings has launched a Thalassemia and Sickle Cell Centre at its flagship quaternary care hospital, Burjeel Medical City (BMC) in Abu Dhabi, in a step towards redefining the standard of care for individuals with inherited blood disorders.The centre was inaugurated in a grand ceremony also attended by Sheikh Khalifa bin Sultan bin Khalifa Al Nahyan, Dr Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, Omran Al Khoori, Board Member, and a number of Burjeel leaders. The opening was also attended by members of the Board of Directors of the Emirates Thalassemia Society and a number of leaders from the Department of Health, Abu Dhabi.Sheikha Shamma bint Sultan bin Khalifa Al Nahyan said in the opening speech she delivered on this occasion: "In my mother's unwavering commitment to thalassemia patients, I have witnessed how compassion, when paired with vision and persistence, can transform countless lives across generations and beyond borders. The newly inaugurated Thalassemia and Sickle Cell Centre by Burjeel Holdings' state-of-the-art facility will provide compassionate and comprehensive care to patients and their families."The centre supports individuals living with thalassemia and sickle cell disease by delivering a holistic, patient-centric, and evidence-based model of care, supported by a multidisciplinary team of world-renowned experts.The centre offers fully integrated outpatient services and a dedicated transfusion unit operating seven days a week. The centre is distinguished by several key differentiators, including extended transfusion services across the UAE via Burjeel's hospital network, internationally validated MRI quantification of iron overload in the heart and liver, and in-house molecular genotyping capabilities. Patients are cared for by experts with decades of experience in managing both pediatric and adult cases of thalassemia and sickle cell disease. With the MENA region reporting considerably high prevalence rates of thalassemia and sickle cell disease, the centre aims to bridge critical gaps in long-term care. The centre's strategic location within a quaternary care facility ensures direct access to advanced medical and surgical subspecialties, enabling seamless referrals and comprehensive management of complications.Prof Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, and Director of the Thalassemia & Sickle Cell Centre, said: 'Our goal is to establish the Thalassemia and Sickle Cell Centre as a regional hub for cutting-edge care and research in rare blood disorders. What makes this centre unique is the combination of global clinical expertise, access to the latest therapies, and the ability to deliver care in line with international guidelines authored by the very people leading the services here. We are not only focused on treatment, but also on improving patients' quality of life and future outcomes through holistic, personalised care.'With an international advisory board of global key opinion leaders, the centre adheres to leading global standards, including those of the Thalassaemia International Federation, with necessary local adaptations to meet the specific needs of patients in the UAE and MENA region. Its continuum of care begins at diagnosis and spans childhood to adulthood, with tailored transition programmes and advanced treatments for conditions including transfusion-dependent β-thalassemia (TDT), non-transfusion-dependent β-thalassemia (NTDT), and sickle cell disease.
The centre will also work closely with the Centre for Research on Rare Blood Disorders (CR-RBD) at BMC, also headed by Prof Khaled Musallam, to identify and enrol eligible patients in global clinical trials, ensuring access to the latest innovations in treatment, including disease-modifying and curative therapies.
Source: Aletihad - Abu Dhabi
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Web Release
17 hours ago
- Web Release
Burjeel Holdings to Operate and Manage ADNOC's New State-of-the-art Das Hospital
Burjeel Holdings PLC, a leading super-specialty healthcare provider in the MENA region, listed on the Abu Dhabi Securities Exchange, has signed a contract to operate and manage ADNOC's Das Hospital at Das Island. This agreement supports ADNOC's commitment to strengthening emergency preparedness, improving healthcare accessibility, and promoting community wellbeing at Das Island. The new Das Hospital is designed to serve as the primary healthcare and emergency response hub for Das Island residents. With its advanced infrastructure and comprehensive range of services, the facility will provide round-the-clock care for ADNOC's workforce, residents, and emergency medical cases arising from nearby locations. Dr. Ghuwaya Al Neyadi, SVP, Group Medical & Wellbeing, ADNOC, said: 'Through this partnership with Burjeel Holdings, ADNOC's state-of-the-art Das Hospital will provide access to top-tier healthcare and emergency services for our employees, reinforcing our Energy for Wellbeing strategy. Our people are our most important asset and ADNOC will continue to prioritize their wellbeing and foster a healthy working environment.' Burjeel Holdings will oversee all clinical and administrative functions of the hospital. The facility includes a broad range of outpatient specialties—such as general surgery, internal medicine, family medicine, occupational health, ENT, dental, ophthalmology, and cardiac and pulmonary unit. It also houses a fully equipped emergency department with a minor operating room, licensed pharmacies, and a dedicated blood bank. John Sunil, Group CEO of Burjeel Holdings, said: 'We are proud to strengthen our partnership with ADNOC through the management of the new Das Hospital. This initiative reflects our continued commitment to extending advanced, high-quality healthcare to strategic and remote locations. Burjeel Holdings remains dedicated to clinical excellence, innovation, and agile operations in support of ADNOC's vision for a safer and healthier future.' Inpatient care is supported by 23 beds across male and female quarantine and critical care units, with the capability to manage both acute and chronic cases. The facility is further supported by advanced diagnostic imaging including X-ray, CT scan, and ultrasound, along with a dedicated physiotherapy and rehabilitation unit. Purpose-built for resilience and emergency responsiveness, the hospital includes a decontamination unit, ambulance bays, and a helipad to support medical evacuations from Das Island. Tele-consultation and tele-counselling services, vaccination programs, and health education initiatives will further enhance access and continuity of care. The Das Hospital builds upon the foundation of the former Das Medical Center, significantly enhancing healthcare provision on the island. With the integration of inpatient facilities, advanced diagnostic capabilities, and surgical services, the new hospital ushers in a new era of comprehensive, high-quality care for the Das community. It will also serve as the first responder for medical emergencies while supporting preventive and rehabilitative care aligned with ADNOC's occupational health guidelines. The new contract builds on Burjeel Holdings' long-standing partnership with ADNOC, which includes the successful operation and management of Al Dhannah Hospital, one of the largest healthcare facilities in the Al Dhafra region. The hospital will operate as part of an integrated care network, supported by the Group's advanced facilities, including its flagship unit, Burjeel Medical City. Burjeel Holdings' network is equipped with state-of-the-art medical technologies and specialized expertise to manage complex cases across a broad spectrum, including trauma, organ transplantation, women's health, pediatrics, orthopedics, spine surgery, and neurosciences, ensuring continuity of care from remote to tertiary-level settings.
Zawya
a day ago
- Zawya
Burjeel Holdings to operate, manage ADNOC's Das Hospital
ABU DHABI - Burjeel Holdings has signed a contract to operate and manage ADNOC's Das Hospital at Das Island. This agreement supports ADNOC's commitment to strengthening emergency preparedness, improving healthcare accessibility, and promoting community wellbeing at Das Island. The new Das Hospital is designed to serve as the primary healthcare and emergency response hub for Das Island residents. With its advanced infrastructure and comprehensive range of services, the facility will provide round-the-clock care for ADNOC's workforce, residents, and emergency medical cases arising from nearby locations. Dr. Ghuwaya Al Neyadi, SVP, Group Medical & Wellbeing, ADNOC, said, 'Through this partnership with Burjeel Holdings, ADNOC's state-of-the-art Das Hospital will provide access to top-tier healthcare and emergency services for our employees, reinforcing our Energy for Wellbeing strategy. Our people are our most important asset and ADNOC will continue to prioritise their wellbeing and foster a healthy working environment." Burjeel Holdings will oversee all clinical and administrative functions of the hospital. The facility includes a broad range of outpatient specialties—such as general surgery, internal medicine, family medicine, occupational health, ENT, dental, ophthalmology, and cardiac and pulmonary unit. It also houses a fully equipped emergency department with a minor operating room, licensed pharmacies, and a dedicated blood bank. Inpatient care is supported by 23 beds across male and female quarantine and critical care units, with the capability to manage both acute and chronic cases. The facility is further supported by advanced diagnostic imaging including X-ray, CT scan, and ultrasound, along with a dedicated physiotherapy and rehabilitation unit.
Zawya
2 days ago
- Zawya
Burjeel Holdings to operate and manage ADNOC's new state-of-the-art Das Hospital
Abu Dhabi, UAE: Burjeel Holdings PLC, a leading super-specialty healthcare provider in the MENA region, listed on the Abu Dhabi Securities Exchange, has signed a contract to operate and manage ADNOC's Das Hospital at Das Island. This agreement supports ADNOC's commitment to strengthening emergency preparedness, improving healthcare accessibility, and promoting community wellbeing at Das Island. The new Das Hospital is designed to serve as the primary healthcare and emergency response hub for Das Island residents. With its advanced infrastructure and comprehensive range of services, the facility will provide round-the-clock care for ADNOC's workforce, residents, and emergency medical cases arising from nearby locations. Dr. Ghuwaya Al Neyadi, SVP, Group Medical & Wellbeing, ADNOC, said: 'Through this partnership with Burjeel Holdings, ADNOC's state-of-the-art Das Hospital will provide access to top-tier healthcare and emergency services for our employees, reinforcing our Energy for Wellbeing strategy. Our people are our most important asset and ADNOC will continue to prioritize their wellbeing and foster a healthy working environment." Burjeel Holdings will oversee all clinical and administrative functions of the hospital. The facility includes a broad range of outpatient specialties—such as general surgery, internal medicine, family medicine, occupational health, ENT, dental, ophthalmology, and cardiac and pulmonary unit. It also houses a fully equipped emergency department with a minor operating room, licensed pharmacies, and a dedicated blood bank. John Sunil, Group CEO of Burjeel Holdings, said: 'We are proud to strengthen our partnership with ADNOC through the management of the new Das Hospital. This initiative reflects our continued commitment to extending advanced, high-quality healthcare to strategic and remote locations. Burjeel Holdings remains dedicated to clinical excellence, innovation, and agile operations in support of ADNOC's vision for a safer and healthier future.' Inpatient care is supported by 23 beds across male and female quarantine and critical care units, with the capability to manage both acute and chronic cases. The facility is further supported by advanced diagnostic imaging including X-ray, CT scan, and ultrasound, along with a dedicated physiotherapy and rehabilitation unit. Purpose-built for resilience and emergency responsiveness, the hospital includes a decontamination unit, ambulance bays, and a helipad to support medical evacuations from Das Island. Tele-consultation and tele-counselling services, vaccination programs, and health education initiatives will further enhance access and continuity of care. The Das Hospital builds upon the foundation of the former Das Medical Center, significantly enhancing healthcare provision on the island. With the integration of inpatient facilities, advanced diagnostic capabilities, and surgical services, the new hospital ushers in a new era of comprehensive, high-quality care for the Das community. It will also serve as the first responder for medical emergencies while supporting preventive and rehabilitative care aligned with ADNOC's occupational health guidelines. The new contract builds on Burjeel Holdings' long-standing partnership with ADNOC, which includes the successful operation and management of Al Dhannah Hospital, one of the largest healthcare facilities in the Al Dhafra region. The hospital will operate as part of an integrated care network, supported by the Group's advanced facilities, including its flagship unit, Burjeel Medical City. Burjeel Holdings' network is equipped with state-of-the-art medical technologies and specialized expertise to manage complex cases across a broad spectrum, including trauma, organ transplantation, women's health, pediatrics, orthopedics, spine surgery, and neurosciences, ensuring continuity of care from remote to tertiary-level settings.
